Hintonia latiflora in type 2 diabetes - A clinical long-term study;Hintonia latiflora bei typ-2-diabetes. Klinische langzeitstudie

Zeitschrift fur Phytotherapie

Volumn 27, Issue 6, 2006, Pages 272-278

  Korecova, Marta ^a   Hladícova, Marie ^b   Korec, Rudolf ^c  

^a IDF President Rc: 425201/734   (Slovakia)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HINTONIA LATIFLORA EXTRACT; INSULIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYTOTHERAPY; POSTPRANDIAL STATE;

EID: 33847616668     PISSN: 0722348X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967719     Document Type: Article

References (21)

1. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years: BMJ 1995; 310(6972): 83-88.
2. Bastien M: Recherches sur les Copalchi, drogues hypoglycemiantes et en particulier sur le Coutarea latiflora D.C. (Rubiacee) [Diss.]. Université de Paris, 1961.
3. Bretzel RG, Voigt K, Schatz H: The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 1998; 106(5): 369-372.
4. Del Prato S, Erkelens DW, Leutenegger M: Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Acta Diabetol 2003; 40(1): 20-27.
5. Drent ML, Tollefsen AT, van Heusden FH, Hoenderdos EB, et al.: Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. Diabetes Nutr Metab 2002; 15(3): 152-159.
6. Guerrera-Analco JA, Hersch-Martinez P, Pedraza-Chaverri J, Navarete A, Mata R: Antihyperglycemic effect of constituents from Hintonia standleyana in Streptozotocin-induced diabetic rats. Planta Med 2005; 71(12): 1099-1105.
7. Herz M, Johns D, Reviriego J, Grossman LD, et al.: A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. Clin Ther 2003; 25(4): 1074-1095.
8. Holstein A, Egberts EH: Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes. Exp Clin Endocrinol Diabetes 2003; 111(7): 405-414.
9. Kaiser H, Geyer H: Zur Pharmakologie der Rinde von Coutarea latiflora D.C. Arch Pharm 1955; 288/60(11-12): 595-608.
10. Korec R, Sensch KH, Zoukas T: Effects of the neoflavonoid coutareagenin, one of the antidiabetic active substances of Hintonia latiflora, on streptozotocin-induced diabetes mellitus in rats. Arzneim.-Forsch./Drug Res. 2000; 50(2): 122-128.
11. Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65(3): 385-411.
12. Kuhr R: Orale Diabetestherapie mit einem Euphorbiazeenextrakt. Landarzt 1953; 29(23): 542-549.
13. Machens R: Zwei Fälle spontaner Regression des Diabetes mellitus Typ II nach Behandlung mit einem Phytotherapeutikum. Erfahrungsheilkunde 1991; 40(6): 433-434.
14. Machens R: Ein Langzeitversuch mit Copalchi-Fluidextrakt, einem pflanzlichen Antidiabeticum. Erfahrungsheilkunde 1992; 41(6): 416-420.
15. Paris R, Bastien M: A propos de l'action hypoglycémicante de deux drogues dénommées »Copalchi«: Coutarea latiflora (Rubiacées) et Croton niveus (Euphorbiacées). Ann Pharm Fr 1960; 18: 205-219.
16. Pinto A, Capasso A, Sorrentino L: Experimental animal studies on the hypoglycemic effects of a Copalchi extract. Arzneim.-Forschung/Drug Res. 1997; 47(7): 829-833.
17. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O: Liver function tests in diabetic patients. Diabetes Care 1984; 7(3): 248-254.
18. Slijepcevic N, Kraus L: The diabetic mouse as an experimental model for measuring the blood-glucose lowering effects of plant extracts and insulin preparations. Acta Therap 1997; 23: 47-58.
19. Stratton IM, Adler AI, Neil HA, Matthews DR, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321(7258): 405-412.
20. Vida F: Erfahrungsbericht mit dem peroralen Antidiabetikum Sucontral. Med Welt 1951; 20: 1623-1624.
21. Winter B: Zur Behandlung des Diabetes mellitus. Hippokrates 1951; 22(9): 249-250.